Skip to content
Showing 1 - 10 of 114 results.
BA.4.6 is now causing an estimated 7% to 10% of new Covid-19 infections, according to data from the US Centers for Disease Control and Prevention.
Paxlovid’s rebounds happened in 1-2% of patients. Should people take Paxlovid for longer periods of time to avoid rebound infections?
Lab studies identify resistance mutations in SARS-CoV-2’s protease, and some circulating variants have them
Scientists at Columbia University have joined a regional consortium of academic and industry partners to accelerate the development of new drugs that target SARS-CoV-2.
Reports of people experiencing a COVID-19 rebound after taking the antiviral treatment Paxlovid
The newer omicron subvariants BA.4 and BA.5 together are accounted for an estimated 6% to 7% of new infections in the U.S. in late May.
CDC issues new guidance on the antiviral therapy medication Paxlovid.
FDA and CDC recommend Paxlovid for people at higher risk of severe COVID-19, including seniors.
CDC is warning of potential "COVID-19 rebound" after a five-day course of the Paxlovid treatment.
Omicron relatives called BA.4 and BA.5 are behind a fresh wave of COVID-19 in South Africa, and could be signs of a more predictable future for SARS-CoV-2.